Literature DB >> 1401024

Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis.

L V Möller1, G J Ruijs, H G Heijerman, J Dankert, L van Alphen.   

Abstract

To determine the frequency of Haemophilus influenzae in sputum from patients with cystic fibrosis (CF), 477 sputum samples obtained from 86 CF patients were analyzed by standard culture and by the in situ immunoperoxidase staining technique with monoclonal antibody 8BD9. H. influenzae was isolated from 109 sputum samples (23%) from 45 patients (52%) and detected by immunoperoxidase staining in 175 sputum samples (37%) obtained from 63 patients (73%). The results of this study demonstrate the frequent presence of H. influenzae in sputum samples from CF patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401024      PMCID: PMC265533          DOI: 10.1128/jcm.30.9.2495-2497.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.

Authors:  D E Roberts; P Cole
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

2.  Detection of Haemophilus influenzae with monoclonal antibody.

Authors:  K Groeneveld; L van Alphen; N J Geelen-van-den Broek; P P Eijk; H C Zanen; R J van Ketel
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321

3.  Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

4.  Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.

Authors:  A Bauernfeind; K Rotter; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

5.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

6.  Haemophilus infection in cystic fibrosis.

Authors:  R J Rayner; E J Hiller; P Ispahani; M Baker
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

7.  Selective media for the quantitation of bacteria in cystic fibrosis sputum.

Authors:  K Wong; M C Roberts; L Owens; M Fife; A L Smith
Journal:  J Med Microbiol       Date:  1984-04       Impact factor: 2.472

8.  Simple method of monitoring colonising microbial load in chronic bronchial sepsis: pilot comparison of reduction in colonising microbial load with antibiotics given intermittently and continuously.

Authors:  D C Currie; E Higgs; S Metcalfe; D E Roberts; P J Cole
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

Review 9.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

10.  Nonculture detection of Haemophilus influenzae in sputum with monoclonal antibodies specific for outer membrane lipoprotein P6.

Authors:  K Groeneveld; L van Alphen; R J van Ketel; L Geelen-van den Broek; P P Eijk; H C Zanen
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

View more
  3 in total

1.  Variation in metabolic enzyme activity of persistent Haemophilus influenzae in respiratory tracts of patients with cystic fibrosis.

Authors:  L V Möller; H Grasselier; J Dankert; L van Alphen
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

2.  Antimicrobial susceptibility of Haemophilus influenzae in the respiratory tracts of patients with cystic fibrosis.

Authors:  L V Möller; A G Regelink; H Grasselier; L van Alphen; J Dankert
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

3.  N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.

Authors:  L V Möller; L van Alphen; H Grasselier; J Dankert
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.